CytoMed Therapeutics (GDTC) Non-Current Receivables (2024 - 2025)

Generated on {Timestamp} © BusinessQuant.com

Generated on {Timestamp} Powered by

CytoMed Therapeutics (GDTC) has disclosed Non-Current Receivables for 2 consecutive years, with $375976.0 as the latest value for Q4 2025.

• Quarterly Non-Current Receivables changed 0.02% to $375976.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $375976.0 through Dec 2025, changed 0.02% year-over-year, with the annual reading at $378942.0 for FY2025, 3.54% up from the prior year.
• Non-Current Receivables hit $375976.0 in Q4 2025 for CytoMed Therapeutics, roughly flat from $375888.2 in the prior quarter.
• In the past five years, Non-Current Receivables ranged from a high of $375976.0 in Q4 2025 to a low of $375888.2 in Q4 2024.

Peer Comparison